GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ORX.ST
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Orexo AB (publ) stock downgraded from Strong Buy Candidate to Hold/Accumulate after Wednesday trading session.
(Updated on Apr 17, 2024)

Buy or Hold candidate since Mar 28, 2024 Gain 12.32% PDF

The Orexo AB (publ) stock price gained 3.43% on the last trading day (Wednesday, 17th Apr 2024), rising from kr16.92 to kr17.50. During the last trading day the stock fluctuated 7.32% from a day low at kr16.40 to a day high of kr17.60. The price has risen in 5 of the last 10 days and is up by 6.06% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 13 thousand shares were bought and sold for approximately kr218.82 thousand.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at kr17.76 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.64% during the next 3 months and, with a 90% probability hold a price between kr17.18 and kr20.19 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ORX.ST Signals & Forecast

The Orexo AB (publ) stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at kr16.60 and kr15.89. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, March 20, 2024, and so far it has risen 20.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Orexo AB (publ) has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Orexo AB (publ) stock

On the downside, the stock finds support just below today's level from accumulated volume at kr14.70 and kr14.30. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Orexo AB (publ) finds support just below today's level at kr14.70. If this is broken, then the next support from accumulated volume will be at kr14.30 and kr14.08.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved kr1.20 between high and low, or 7.32%. For the last week, the stock has had daily average volatility of 3.78%.

The Orexo AB (publ) stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: kr16.69 (-4.65%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from a pivot bottom found 18 days ago.)

Trading Expectations (ORX.ST) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Orexo AB (publ) to open at kr17.17, and during the day (based on 14 day Average True Range), to move between kr16.68 and kr18.32, which gives a possible trading interval of +/-kr0.82 (+/-4.68%) up or down from last closing price. If Orexo AB (publ) takes out the full calculated possible swing range there will be an estimated 9.36% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ kr14.70, some kr2.80 (16.00%) from the current price of kr17.50, our system finds the risk reward attractive.

Is Orexo AB (publ) stock A Buy?

Orexo AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Orexo AB (publ) of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
kr17.17 ( 1.90%) kr17.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ORX.ST

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.37 4.95 %
R2 17.91 2.33 %
R1 17.63 0.715 %
Current price: 17.50
Support S1 16.71 -4.52 %
S2 16.43 -6.14 %
S3 15.97 -8.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 17.50
Support S1 14.70 -16.00%
S2 14.30 -18.29%
S3 14.08 -19.54%

FAQ

What is the symbol for Orexo AB (publ) Stock and on which exchange is it traded?
The symbol for Orexo AB (publ) is ORX.ST and it is traded on the OMX (Stockholm Stock Exchange).

Should I buy or sell Orexo AB (publ) Stock?
Orexo AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Orexo AB (publ) Stock?
Orexo AB (publ) Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Orexo AB (publ) Stock.

What's the current price of Orexo AB (publ) Stock?
As of the end of day on the 2024-04-17, the price of an Orexo AB (publ) (ORX.ST) share was kr17.50.

What is the 52-week high and low for Orexo AB (publ) Stock?
The 52-week high for Orexo AB (publ) Stock is kr20.10 and the 52-week low is kr8.44.

What is the market capitalization of Orexo AB (publ) Stock?
As of the 2024-04-17, the market capitalization of Orexo AB (publ) is 602.867M.

When is the next earnings date for Orexo AB (publ)?
The upcoming earnings date for Orexo AB (publ) is May 08, 2024.
Click to get the best stock tips daily for free!

About Orexo AB (publ)

Orexo AB (publ) Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone res... ORX.ST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT